Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Viktoriya V, Dubrovskaya"'
Autor:
Ludmila B, Toporkova, Viktoriya V, Dubrovskaya, Ludmila V, Sakhno, Marina A, Tikhonova, Elena R, Chernykh, Valentina N, Buneva, Georgy A, Nevinsky, Vladimir A, Kozlov, Irina A, Orlovskaya
Publikováno v:
Russian journal of immunology : RJI : official journal of Russian Society of Immunology. 7(3)
Lymphocyte proliferation and apoptosis at different stages of the development of the autoimmune disorder in MRL/MpJ-lpr mice was studied. Hematopoietic progenitor colony formation during the course of the disease was characterized. A detectable diffe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d367fb2a7cbb16211229bf8d335bb9b8
https://pubmed.ncbi.nlm.nih.gov/12674934
https://pubmed.ncbi.nlm.nih.gov/12674934
Autor:
Aljedani SS; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, Washington, United States of America., Liban TJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, Washington, United States of America., Tran K; The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, California, United States of America., Phad G; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Singh S; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, Washington, United States of America., Dubrovskaya V; The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, California, United States of America., Pushparaj P; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Martinez-Murillo P; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Rodarte J; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, Washington, United States of America., Mileant A; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America., Mangala Prasad V; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America., Kinzelman R; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America., O'Dell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Lee KK; Department of Medicinal Chemistry, University of Washington, Seattle, Washington, United States of America., Karlsson Hedestam GB; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Wyatt RT; The Scripps Research Institute, IAVI Neutralizing Antibody Center, La Jolla, California, United States of America.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Pancera M; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, Washington, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2021 Sep 24; Vol. 17 (9), pp. e1009543. Date of Electronic Publication: 2021 Sep 24 (Print Publication: 2021).
Autor:
Phad GE; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Pushparaj P; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Tran K; International AIDS Vaccine Initiative, Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA., Dubrovskaya V; International AIDS Vaccine Initiative, Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA., Àdori M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Martinez-Murillo P; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Vázquez Bernat N; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Singh S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Dionne G; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY., O'Dell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Bhullar K; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Narang S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Sorini C; Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Villablanca EJ; Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Sundling C; Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Murrell B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Shapiro L; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY., Pancera M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Martin M; Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden., Corcoran M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Wyatt RT; International AIDS Vaccine Initiative, Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA., Karlsson Hedestam GB; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2020 Feb 03; Vol. 217 (2).
Autor:
Dubrovskaya V; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Tran K; International AIDS Vaccine Initiative, Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, CA 92037, USA., Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Guenaga J; International AIDS Vaccine Initiative, Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, CA 92037, USA., Wilson R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Bale S; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Cottrell CA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Turner HL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Seabright G; School of Biological Sciences, University of Southampton, Southampton, UK., O'Dell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Yang L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Feng Y; International AIDS Vaccine Initiative, Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, CA 92037, USA., Leaman DP; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Vázquez Bernat N; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 171 77, Sweden., Liban T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Louder M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., McKee K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Bailer RT; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Movsesyan A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Doria-Rose NA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Pancera M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Karlsson Hedestam GB; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 171 77, Sweden., Zwick MB; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Crispin M; School of Biological Sciences, University of Southampton, Southampton, UK., Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA., Ward AB; International AIDS Vaccine Initiative, Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA., Wyatt RT; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; International AIDS Vaccine Initiative, Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, CA 92037, USA; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: wyatt@scripps.edu.
Publikováno v:
Immunity [Immunity] 2019 Nov 19; Vol. 51 (5), pp. 915-929.e7. Date of Electronic Publication: 2019 Nov 12.
Autor:
Khan SN; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA., Sok D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA., Tran K; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA., Movsesyan A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA., Dubrovskaya V; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA., Wyatt RT; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA.
Publikováno v:
Journal of virology [J Virol] 2019 May 15; Vol. 93 (11). Date of Electronic Publication: 2019 May 15 (Print Publication: 2019).
Autor:
Khan SN; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA., Sok D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA., Tran K; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA., Movsesyan A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA., Dubrovskaya V; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA., Wyatt RT; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA wyatt@scripps.edu.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA.; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA.
Publikováno v:
Journal of virology [J Virol] 2018 Aug 29; Vol. 92 (18). Date of Electronic Publication: 2018 Aug 29 (Print Publication: 2018).
Autor:
Dubrovskaya V; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Guenaga J; IAVI Neutralizing Center at TSRI, Department of Research and Development, International AIDS Vaccine Initiative, La Jolla, California, United States of America., de Val N; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Wilson R; IAVI Neutralizing Center at TSRI, Department of Research and Development, International AIDS Vaccine Initiative, La Jolla, California, United States of America., Feng Y; IAVI Neutralizing Center at TSRI, Department of Research and Development, International AIDS Vaccine Initiative, La Jolla, California, United States of America., Movsesyan A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Karlsson Hedestam GB; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Ward AB; IAVI Neutralizing Center at TSRI, Department of Research and Development, International AIDS Vaccine Initiative, La Jolla, California, United States of America.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; The Scripps CHAVI-ID, The Scripps Research Institute, La Jolla, California, United States of America., Wyatt RT; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Center at TSRI, Department of Research and Development, International AIDS Vaccine Initiative, La Jolla, California, United States of America.; The Scripps CHAVI-ID, The Scripps Research Institute, La Jolla, California, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2017 Sep 13; Vol. 13 (9), pp. e1006614. Date of Electronic Publication: 2017 Sep 13 (Print Publication: 2017).
Autor:
Guenaga J; IAVI Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, CA 92037, USA., Garces F; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., de Val N; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Stanfield RL; IAVI Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Dubrovskaya V; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Higgins B; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Carrette B; IAVI Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, CA 92037, USA., Ward AB; IAVI Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA; Scripps Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID), La Jolla, CA 92037, USA., Wilson IA; IAVI Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA; Scripps Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID), La Jolla, CA 92037, USA; The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: wilson@scripps.edu., Wyatt RT; IAVI Neutralizing Antibody Center at The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Scripps Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery (CHAVI-ID), La Jolla, CA 92037, USA. Electronic address: wyatt@scripps.edu.
Publikováno v:
Immunity [Immunity] 2017 May 16; Vol. 46 (5), pp. 792-803.e3.
Autor:
Martinez-Murillo P; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden., Tran K; IAVI Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Guenaga J; IAVI Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Lindgren G; Immunology and Allergy Unit, Department of Medicine, Karolinska Institutet, 171 77 Solna, Sweden., Àdori M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden., Feng Y; IAVI Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Phad GE; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden., Vázquez Bernat N; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden., Bale S; IAVI Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Ingale J; IAVI Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., Dubrovskaya V; IAVI Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA., O'Dell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Pramanik L; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden., Spångberg M; Astrid Fagraeus Laboratory, Comparative Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden., Corcoran M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden., Loré K; Immunology and Allergy Unit, Department of Medicine, Karolinska Institutet, 171 77 Solna, Sweden., Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Wyatt RT; IAVI Neutralizing Antibody Center, Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: wyatt@scripps.edu., Karlsson Hedestam GB; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 77 Stockholm, Sweden. Electronic address: gunilla.karlsson.hedestam@ki.se.
Publikováno v:
Immunity [Immunity] 2017 May 16; Vol. 46 (5), pp. 804-817.e7.
Autor:
Guenaga J; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA., Dubrovskaya V; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA., de Val N; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA., Sharma SK; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA., Carrette B; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA., Ward AB; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA., Wyatt RT; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, USA Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA wyatt@scripps.edu.
Publikováno v:
Journal of virology [J Virol] 2015 Dec 30; Vol. 90 (6), pp. 2806-17. Date of Electronic Publication: 2015 Dec 30.